Olympus’s consolidated net sales for the fiscal year ending March 2026 exceeded the previous forecast, reaching 10,106.76 billion yen, with profits also increasing. Contributions came from effective promotional activities in the North American endoscopy business and gains from asset sales.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"7733","jir_company_name":"Olympus Corporation","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-05-12","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/05\/7733-20260512-04.pdf","jir_short_summary":"Olympus's consolidated net sales for the fiscal year ending March 2026 exceeded the previous forecast, reaching 10,106.76 billion yen, with profits also increasing. Contributions came from effective promotional activities in the North American endoscopy business and gains from asset sales.","jir_summary":"### Financial Overview\nOlympus's consolidated net sales for the fiscal year ending March 2026 reached 10,106.76 billion yen, surpassing the previous forecast. Profits also exceeded expectations, with operating income at 97.12 billion yen and net income attributable to owners of the parent at 68.17 billion yen. The North American endoscope solution sales promotions and gains from asset sales contributed to this result.\n\n### Future Outlook and Impact\nThe positive performance this period was driven by the effectiveness of promotional activities and revenue increases from asset sales. Moving forward, the company aims to secure stable profits through continued expansion of the endoscope business and ongoing asset sales. Despite potential fluctuations due to exchange rates and market trends, steady financial performance is expected.","jir_financial_highlights":"Net Sales: 10,106.76 billion yen (Exceeded the previous forecast by +126.76 billion yen (+1.3%))\nOperating Income: 97.12 billion yen (Exceeded the previous forecast by +10.12 billion yen (+11.6%))\nNet Income Attributable to Owners of Parent: 68.17 billion yen (Exceeded the previous forecast by +9.17 billion yen (+15.5%))","jir_category":"","jir_hashtags":"#Olympus, #IRFinancialResults, #JapaneseStocks","jir_key_figures":"Net Sales: 10,106.76 billion yen (+1.3%)\nOperating Income: 97.12 billion yen (+11.6%)\nNet Income Attributable to Owners of the Parent: 68.17 billion yen (+15.5%)","jir_meta_title":"\u3010Olympus\u30112026 Full-Year Financial Results\uff5cIncrease in Net Sales and Profits","jir_meta_description":"Olympus's net sales for the fiscal year ending March 2026 reached 10,106.76 billion yen, with profits also increasing. Promotional activities and gains from asset sales contributed to the latest financial results.","jir_og_title":"\u3010Olympus\u30112026 Full-Year Financial Results\uff5cIncrease in Net Sales and Profits","jir_og_description":"Olympus's fiscal year ending March 2026 shows sales and profits exceeding expectations, supported by successful promotional activities and gains from asset sales.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":6918,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-48264","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n